Bhatti, Gurjit KaurPahwa, ParasGupta, AnshikaNavik, UmashankerBhatti, Jasvinder Singh2024-01-212024-08-142024-01-212024-08-142021-07-029789813368279978981336826210.1007/978-981-33-6827-9_9http://10.2.3.109/handle/32116/4294Recent knowledge of the role of signaling pathways and their underlying mechanisms in the pathogenesis of several diseases may lead to the development of therapeutic strategies. In the recent time, several drug molecules have been developed which target the cell signaling pathways and may be used in combination with other standard therapies for the synergistic effects in reducing the lung cancer pathophysiology across the world. Further, some of predictive biomarkers have been identified. The current chapter deals with the involvement of signaling pathways in the development of lung cancer and further new therapeutic approaches that intend to pave the way for the development of improved clinical treatment of lung cancer. � The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2021.en-USDrug moleculesLung cancerSignalling pathwaysVaccineBook chapterhttps://link.springer.com/10.1007/978-981-33-6827-9_9